THE N34S MUTATION OF SERINE PROTEASE INHIBITOR, KAZAL TYPE 1, IN PATIENTS WITH CHRONIC PANCREATITIS AND PANCREATIC CANCER

(1) DEPARTMENT OF DIGESTIVE TRACTDISEASES, MEDICAL UNIVERSITY OFLODZ, Lodz, Poland

(2) Department of Pathology, Laboratory of Molecular Genetics, Institute of Polish Mother?s Mem



This item was part of the Pancreas II session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A328